Flamingo Therapeutics’ Post

Cohort study aims to establish whether anterior vs posterior tumor extension may represent a prognostic factor in oral tongue and floor squamous cell carcinoma. https://ja.ma/3ODk2Q9

𝙀𝙛𝙛𝙞𝙘𝙖𝙘𝙮 𝙖𝙣𝙙 𝙩𝙤𝙭𝙞𝙘𝙞𝙩𝙮 𝙤𝙛 𝙖𝙣𝙡𝙤𝙩𝙞𝙣𝙞𝙗 𝙥𝙡𝙪𝙨 𝙘𝙖𝙢𝙧𝙚𝙡𝙞𝙯𝙪𝙢𝙖𝙗 𝙫𝙚𝙧𝙨𝙪𝙨 𝙖𝙣𝙡𝙤𝙩𝙞𝙣𝙞𝙗 𝙥𝙡𝙪𝙨 𝙎-1 𝙖𝙨 𝙨𝙚𝙘𝙤𝙣𝙙-𝙡𝙞𝙣𝙚 𝙩𝙝𝙚𝙧𝙖𝙥𝙮 𝙛𝙤𝙧 𝙖𝙙𝙫𝙖𝙣𝙘𝙚𝙙 𝙚𝙨𝙤𝙥𝙝𝙖𝙜𝙚𝙖𝙡 𝙨𝙦𝙪𝙖𝙢𝙤𝙪𝙨 𝙘𝙚𝙡𝙡 𝙘𝙖𝙧𝙘𝙞𝙣𝙤𝙢𝙖: 𝘼 𝙧𝙚𝙖𝙡-𝙬𝙤𝙧𝙡𝙙 𝙧𝙚𝙩𝙧𝙤𝙨𝙥𝙚𝙘𝙩𝙞𝙫𝙚 𝙨𝙩𝙪𝙙𝙮. A recent study explores #anlotinib plus #camrelizumab as a #secondlinetherapy for advanced #esophagealsquamouscell #carcinoma. Promising results show longer #survival time, improved #diseasecontrol, and manageable #sideeffects.  Read more here:  https://lnkd.in/gVBZT7KW

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study

Durable antitumor activity (ORR 49%) and survival (51% at 2-years) in recurrent/metastatic Merkel Cell Carcinoma, a further step for the patients

We are glad to show our most recent article. PD-L1 expression in non-small cell lung carcinoma in Latin America: a systematic review and meta-analysis https://lnkd.in/eeR4bUxb

MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study. https://lnkd.in/eejbvmQt

The neoadjuvant combination of camrelizumab, nab-paclitaxel & cisplatin demonstrated statistically significant enhancements in pCRs compared with solitary chemotherapy in resectable locally advanced esophageal squamous cell carcinoma. https://lnkd.in/ei3axH2q

Gain valuable insights into how collaboration among different healthcare professionals can lead to early detection and better outcomes for patients with advanced cases of basal cell carcinoma (BCC) and advanced cutaneous squamous cell carcinoma (CSCC). Register here: https://okt.to/jbM5hq

Transitional Cell Carcinoma Illustration showing the enhancement of transitional cell carcinoma across the 4 phases of CT. https://lnkd.in/eui6ynYx

Gain valuable insights into how collaboration among different healthcare professionals can lead to early detection and better outcomes for patients with advanced cases of basal cell carcinoma (BCC) and advanced cutaneous squamous cell carcinoma (CSCC). Register here: https://okt.to/RpId8e